Table:
begin	end	state
1	50	cytoplasmic
51	72	transmembrane
73	190	non-cytoplasmic
191	192	cytoplasmic
193	196	non-cytoplasmic
197	220	transmembrane
221	231	non-cytoplasmic
232	265	transmembrane
266	280	cytoplasmic
281	304	transmembrane
305	330	non-cytoplasmic
331	349	transmembrane
350	378	cytoplasmic
379	399	transmembrane
400	410	non-cytoplasmic
411	441	transmembrane
442	443	non-cytoplasmic
444	446	cytoplasmic
447	469	transmembrane
470	474	cytoplasmic
475	481	non-cytoplasmic

Input:
>WP_058932742.1 NCBI__GCF_001484605.1:WP_058932742.1
MRPPTCRKHHHPSRDVCSGCNGASLATPPKWRIFILRSTPKGSPHRRPGGLLKVIGAVFA
SVVAILLVVAPASQATSPSPTPSPSITTFQNNISGFLRDDARAPIADVTITARSGDFEGT
ATSAANGSWSIGVPVQGTYEIELDESTLPEGIKLAEGQENPRSVTFSQTSNLSVIFAFGE
GIVVQQQDFGQNLVNRLVAGLSFGLLLALASVGLSLIFGTTGLTNFAHGEMVTLGAVLVF
AFNAIGLPFWLALILSLLGGGLFGYIQDAGLWKPLRRRGTGLVPMMIVSIGLALAVRYVI
QFYFGGATQQLPFAQSAEIQLGPISISPNNLWSLIVSAVVIALLGIVLLKTRLGKATRAV
ADNPALAAASGIDVDSVIRIVWVTGGMLASLGGILWAYYRPGVTFDMGSQILLLIFAGVT
LGGLGTVFGALIGSIIVGIFVELTTVFGLAADLKYVGALFIMIVVLLFRPQGILGRRERV
G

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server